Healio Psoriatic Disease Current Issue
The following articles appeared in the print edition of Healio Psoriatic Disease.
Table of Contents
- Patients with psoriasis, skin of color experience disparities in identification, treatment Rebecca L. Forand
-
- Progress needed in treating patients with skin of color and psoriasis Joel M. Gelfand, MD, MSCE
- Dyschromia, dyspigmentation present unique challenges for skin of color Rebecca L. Forand
- National Psoriasis Foundation recommends COVID-19 vaccine in pandemic guidelines Rebecca L. Forand
- Psoriasis, metabolic syndrome associated with cardiovascular risk Rebecca L. Forand
- Deucravacitinib shows superiority to placebo, apremilast in treating psoriasis Rebecca L. Forand
- Depression rate lower with apremilast treatment for psoriasis, psoriatic arthritis Madison Weller
- Switching to risankizumab may improve treatment response in patients with psoriasis Madison Weller
- Two studies demonstrate effectiveness of retapamulin to treat impetigo Rebecca L. Forand
-
- Systemic, cardiovascular issues more likely in Black patients with cutaneous sarcoidosis Madison Weller
- TNF inhibitors, methotrexate may not worsen outcomes in COVID-19 Rob Volansky
- Patient satisfaction high with teledermatology visits during pandemic Rebecca L. Forand
- Patients with PsA respond better to biologic DMARDs vs. those with RA at 12 years Jason Laday
- TNF inhibitors do not increase solid cancer risk in PsA Jason Laday
- Acitretin, apremilast, methotrexate effective in treating ICI-mediated psoriasis Rebecca L. Forand